Yoshikazu Yonemitsu

Company: GAIA Advanced Stem Cells

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Evaluating Clinical Potential of Different NK Subtypes 2:30 pm

Discuss how different NK subtypes perform against various cancer types and disease models How do different NK phenotypes influence therapeutic outcomes? Is it best to have a homogenous or heterogenous NK product?Read more

day: Day 2 - Track B - PM

Multi-Donor-Derived Approach Generating a Unique Phenotypic Profile of NK Cells that can Eliminate Solid Tumors 4:00 pm

Understanding the scientific basis and mechanisms behind combining NK cells from multiple donors predefined HLA-C and KIRs genotypes into one product Highlighting key advantages of this approach including advanced NK education and license for kill Showcasing clinical data of this approach from three different clinical trials in patients with solid tumorsRead more

day: Day 1 PM